Wenmin Liu

Nanyang, 473061, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Phenylpropanoid-homoisoflavonoid derivatives from the fruits of Hippophae rhamnoides L. and their hepatoprotective and hypolipidemic activities.

Phenylpropanoid-homoisoflavonoid derivatives from the fruits of Hippophae rhamnoides L. and their hepatoprotective and hypolipidemic activities.

Journal: Food & function

Published: January 28, 2026

Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinoline-O-carbamate derivatives as AChE/MAO-B dual inhibitors for the treatment of Alzheimer's disease.

Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinoline-O-carbamate derivatives as AChE/MAO-B dual inhibitors for the treatment of Alzheimer's disease.

Journal: RSC medicinal chemistry

Published: December 17, 2025

Imidazo[1,2-a]pyridine-based HDAC6 inhibitor a17 for the treatment of Alzheimer's disease.

Imidazo[1,2-a]pyridine-based HDAC6 inhibitor a17 for the treatment of Alzheimer's disease.

Journal: European journal of pharmacology

Published: August 17, 2025

A comprehensive review on pain: Model, target, therapy, and prospect (Review).

A comprehensive review on pain: Model, target, therapy, and prospect (Review).

Journal: International journal of molecular medicine

Published: June 12, 2025

Development of novel rivastigmine derivatives as selective BuChE inhibitors for the treatment of AD.

Development of novel rivastigmine derivatives as selective BuChE inhibitors for the treatment of AD.

Journal: Bioorganic chemistry

Published: December 13, 2024

Discovery of novel butyrylcholinesterase inhibitors for treating Alzheimer's disease.

Discovery of novel butyrylcholinesterase inhibitors for treating Alzheimer's disease.

Journal: Acta pharmaceutica Sinica. B

Published: August 30, 2024

Development of novel salicylic acid-donepezil-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease.

Development of novel salicylic acid-donepezil-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: July 06, 2023

Achieving high carrier separation over Bi4O5I2through Ni doping for improved photocatalytic CO2reduction.

Achieving high carrier separation over Bi4O5I2through Ni doping for improved photocatalytic CO2reduction.

Journal: Nanotechnology

Published: May 10, 2023

Development of naringenin-O-alkylamine derivatives as multifunctional agents for the treatment of Alzheimer's disease.

Development of naringenin-O-alkylamine derivatives as multifunctional agents for the treatment of Alzheimer's disease.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: February 23, 2022

Development of naringenin-O-carbamate derivatives as multi-target-directed liagnds for the treatment of Alzheimer's disease.

Development of naringenin-O-carbamate derivatives as multi-target-directed liagnds for the treatment of Alzheimer's disease.

Journal: Bioorganic & medicinal chemistry letters

Published: September 22, 2021

Design, synthesis and evaluation of cinnamic acid hybrids as multi-target-directed agents for the treatment of Alzheimer's disease.

Design, synthesis and evaluation of cinnamic acid hybrids as multi-target-directed agents for the treatment of Alzheimer's disease.

Journal: Bioorganic chemistry

Published: February 12, 2021

Development of genistein-O-alkylamines derivatives as multifunctional agents for the treatment of Alzheimer's disease.

Development of genistein-O-alkylamines derivatives as multifunctional agents for the treatment of Alzheimer's disease.

Journal: Bioorganic chemistry

Published: August 23, 2020

Showing 1-12 of 32

Last Updated: 09/26/2026